The article A Deeper Look at Atai Life Sciences’ R&D Day was originally published on Microdose. Today, atai Life Sciences (Nasdaq: ATAI) held its...
Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with The post Consolidation...
The article News You Might Have Missed: Oct 17th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
IntelGenx Corp. (IGX.TO) on Thursday provided an update on its collaboration with its strategic partner, Atai Life Sciences (atai) for the development...
The article News You Might Have Missed: Oct 11th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Source: Dr. Elemer Piros 10/06/2022 Read to learn why ROTH Capital Partners gave Atai Life Sciences NV a Buy rating and a target price 10...
The article atai Life Sciences Doses First Patient in New DMT Clinical Trial was originally published on Microdose. While atai Life Sciences (Nasdaq:...
The article Can Psychedelic Stocks Like MindMed and atai Ever Recover? was originally published on Microdose. Should investors begin ringing the funeral...
The Daily Hit is a recap of cannabis business news for October 5, 2022. ON THE SITE NBA Legend Isiah Thomas Hopes To Score In His...
- atai has dosed the first subject in their Phase 1 single-ascending dose (SAD) trial of VLS-01 with topline results expected in H1 2023. - VLS-01...